Total Payments
$383.72
2023 Payments
$61.40
Companies
11
Transactions
19
Medicare Patients
319
Medicare Billing
$4,869
Payment Breakdown by Category
Food & Beverage$383.72 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $383.72 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $130.16 | 6 | $0 (2018) |
| MERZ NORTH AMERICA, INC. | $70.91 | 1 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $37.62 | 3 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $29.40 | 1 | $0 (2023) |
| Novo Nordisk Inc | $25.47 | 2 | $0 (2022) |
| GlaxoSmithKline, LLC. | $18.83 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.65 | 1 | $0 (2023) |
| Lilly USA, LLC | $16.40 | 1 | $0 (2021) |
| ABBVIE INC. | $14.35 | 1 | $0 (2023) |
| PFIZER INC. | $11.99 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $61.40 | 3 | Otsuka America Pharmaceutical, Inc. ($29.40) |
| 2022 | $56.74 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($24.45) |
| 2021 | $41.58 | 3 | Lilly USA, LLC ($16.40) |
| 2020 | $70.91 | 1 | MERZ NORTH AMERICA, INC. ($70.91) |
| 2018 | $42.51 | 2 | Indivior Inc. ($42.51) |
| 2017 | $110.58 | 6 | Indivior Inc. ($87.65) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: PSYCHIATRY | ||||||
| 02/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: RESPIRATORY | ||||||
| 03/16/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Gastroenterology | ||||||
| 03/10/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Diabetes | ||||||
| 01/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Gastroenterology | ||||||
| 11/10/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Gastroenterology | ||||||
| 11/09/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Neuroscience | ||||||
| 10/12/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Diabetes | ||||||
| 01/29/2020 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | Cash or cash equivalent | $70.91 | General |
| 03/21/2018 | Indivior Inc. | SUBLOCADE (Drug), SUBOXONE SUBLINGUAL FILM | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: OUD | ||||||
| 01/25/2018 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: OUD | ||||||
| 10/18/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $19.87 | General |
| Category: OUD | ||||||
| 09/14/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $28.58 | General |
| Category: OUD | ||||||
| 05/09/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: OUD | ||||||
| 02/08/2017 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/06/2017 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $10.94 | General |
| Category: Addiction Medicine | ||||||
| 01/10/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $19.10 | General |
| Category: OUD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 34 | 62 | $1,040 | $420.00 |
| 2022 | 7 | 160 | 234 | $5,778 | $2,359 |
| 2021 | 6 | 125 | 176 | $5,494 | $2,090 |
Total Patients
319
Total Services
472
Medicare Billing
$4,869
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 22 | 30 | $720.00 | $285.60 | 39.7% |
| 85610 | Blood test, clotting time | Office | 2023 | 12 | 32 | $320.00 | $134.40 | 42.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 22 | 24 | $2,280 | $842.25 | 36.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 51 | 70 | $1,680 | $671.00 | 39.9% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 16 | 20 | $380.00 | $299.35 | 78.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 21 | 34 | $646.00 | $261.14 | 40.4% |
| 85610 | Blood test, clotting time | Office | 2022 | 14 | 42 | $420.00 | $177.46 | 42.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 24 | 32 | $192.00 | $71.11 | 37.0% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 12 | 12 | $180.00 | $36.31 | 20.2% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 27 | 28 | $2,660 | $989.24 | 37.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 36 | 40 | $960.00 | $388.40 | 40.5% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 12 | 14 | $784.00 | $231.70 | 29.6% |
| 85610 | Blood test, clotting time | Office | 2021 | 14 | 48 | $480.00 | $205.92 | 42.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 15 | 24 | $456.00 | $186.48 | 40.9% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 21 | 22 | $154.00 | $88.44 | 57.4% |
About Dr. Mark Grenkoski, M.D
Dr. Mark Grenkoski, M.D is a Emergency Medicine healthcare provider based in Robbinsville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174567754.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Grenkoski, M.D has received a total of $383.72 in payments from pharmaceutical and medical device companies, with $61.40 received in 2023. These payments were reported across 19 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($383.72).
As a Medicare-enrolled provider, Grenkoski has provided services to 319 Medicare beneficiaries, totaling 472 services with total Medicare billing of $4,869. Data is available for 3 years (2021–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine, Emergency Medicine
- Location Robbinsville, NC
- Active Since 06/15/2006
- Last Updated 08/01/2023
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1174567754
Products in Payments
- SUBOXONE SUBLINGUAL FILM (Drug) $108.19
- XIFAXAN (Drug) $37.62
- ABILIFY MAINTENA (Drug) $29.40
- Ozempic (Drug) $25.47
- SUBLOCADE (Drug) $21.97
- TRELEGY ELLIPTA (Drug) $18.83
- TRINTELLIX (Drug) $17.65
- EMGALITY (Drug) $16.40
- VRAYLAR (Drug) $14.35
- LYRICA (Drug) $11.99
- Zubsolv (Drug) $10.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.